(4S,7S,10S,11R)-4-((1H-indol-3-yl)methyl)-11-amino-10-hydroxy-7-isobutyl-3,6,9-trioxo-2-oxa-5,8,14-triazaheptadecan-17-oic Acid

ID: ALA5191937

Chembl Id: CHEMBL5191937

PubChem CID: 168285307

Max Phase: Preclinical

Molecular Formula: C26H39N5O7

Molecular Weight: 533.63

Associated Items:

Names and Identifiers

Canonical SMILES:  COC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](O)[C@H](N)CCNCCC(=O)O

Standard InChI:  InChI=1S/C26H39N5O7/c1-15(2)12-20(30-25(36)23(34)18(27)8-10-28-11-9-22(32)33)24(35)31-21(26(37)38-3)13-16-14-29-19-7-5-4-6-17(16)19/h4-7,14-15,18,20-21,23,28-29,34H,8-13,27H2,1-3H3,(H,30,36)(H,31,35)(H,32,33)/t18-,20+,21+,23+/m1/s1

Standard InChI Key:  MKKYXMZTDFKYBR-ANZJIFDASA-N

Alternative Forms

  1. Parent:

    ALA5191937

    ---

Associated Targets(Human)

ERAP1 Tchem Endoplasmic reticulum aminopeptidase 1 (581 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ERAP2 Tchem Endoplasmic reticulum aminopeptidase 2 (387 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
IL1RN Tchem Interleukin-1 receptor antagonist protein (102 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 533.63Molecular Weight (Monoisotopic): 533.2849AlogP: 0.04#Rotatable Bonds: 16
Polar Surface Area: 195.87Molecular Species: ZWITTERIONHBA: 8HBD: 7
#RO5 Violations: 2HBA (Lipinski): 12HBD (Lipinski): 8#RO5 Violations (Lipinski): 3
CX Acidic pKa: 3.86CX Basic pKa: 9.58CX LogP: -2.57CX LogD: -2.64
Aromatic Rings: 2Heavy Atoms: 38QED Weighted: 0.12Np Likeness Score: 0.27

References

1. Vourloumis D, Mavridis I, Athanasoulis A, Temponeras I, Koumantou D, Giastas P, Mpakali A, Magrioti V, Leib J, van Endert P, Stratikos E, Papakyriakou A..  (2022)  Discovery of Selective Nanomolar Inhibitors for Insulin-Regulated Aminopeptidase Based on α-Hydroxy-β-amino Acid Derivatives of Bestatin.,  65  (14.0): [PMID:35833347] [10.1021/acs.jmedchem.2c00904]

Source